FAYROSE FOUAD ABODESHISHA RPA-C
Prescription History 1245482413
Physician Assistant - Surgical in New York, NY
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for FAYROSE FOUAD ABODESHISHA RPA-C, an active Surgical specialist practicing in New York, NY. Our medical registry currently tracks 2 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 27 documented patient claims. Among these therapy options, the most frequently utilized medication is Wegovy, which accounts for 14 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other NY PrescribersVs. NY Avg |
|---|---|---|---|
| WegovySemaglutide | 14 | $1,358.37▼ below NY avg | ▼ Less than typical |
About Wegovy: Semaglutide is used to lower the risk of death from heart attack and stroke in people with heart disease who are overweight or obese. Show more ▾ It is also used by certain overweight people (such as those who are obese or have weight-related medical problems) to help lose weight. Semaglutide is used along with a doctor-approved exercise, behavior change, and reduced-calorie diet program. Losing weight and keeping it off can lessen the many health risks of being overweight, including heart disease, diabetes, high blood pressure, and a shorter life. Semaglutide is similar to a natural hormone in your body (incretin). It works by controlling your appetite. A glucagon-like peptide and GLP-1 agonist used to enhance glycemic control of TYPE 2 DIABETES MELLITUS, and for OBESITY MANAGEMENT. In 2024, this provider wrote 14 Medicare prescriptions for Wegovy, about 66% of the volume of the typical New York prescriber of this medication (21.1). Medicare paid an average of $1,358.37 per fill, versus $1,423.26 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 14 30-Day Fills standardized to 30-day supplies 392 Days of Medication total across all patients in 2024 | |||
| MounjaroTirzepatide | 13 | $1,064.34▼ below NY avg | ▼ Less than typical |
About Mounjaro: Tirzepatide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. It lowers blood sugar by causing the release of your body's natural insulin and decreasing the amount of sugar your liver makes. An analog of GASTRIC INHIBITORY POLYPEPTIDE and agonist of GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE RECEPTOR and GLUCAGON-LIKE PEPTIDE-1 RECEPTOR used to enhance glycemic control of TYPE 2 DIABETES MELLITUS. In 2024, this provider wrote 13 Medicare prescriptions for Mounjaro, about a quarter of the volume of the typical New York prescriber of this medication (54.3). Medicare paid an average of $1,064.34 per fill, versus $1,279.00 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 13 30-Day Fills standardized to 30-day supplies 366 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for FAYROSE FOUAD ABODESHISHA RPA-C is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Surgical prescribing approach at this New York, NY practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among NY prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
